Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit

Synapse

Volumn 31, Issue 3, 1999, Pages 229-239

  Hanania, Taleen ^a   Hillman, Gilbert R ^a   Johnson, Kenneth M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Acetylcholine; Frontal cortex; GABA; Olfactory cortex; Release; Sensitization

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; RECEPTOR SUBUNIT;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; IMMUNOCYTOCHEMISTRY; LOCOMOTION; MALE; NONHUMAN; OLFACTORY CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSITIZATION;

ANIMALS; CORPUS STRIATUM; EXCITATORY AMINO ACID ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANES; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; PHENCYCLIDINE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS; UP-REGULATION;

EID: 0033103433     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990301)31:3<229::AID-SYN8>3.0.CO;2-3     Document Type: Article

References (53)

1. Albin RL, Young AB, Penney JB. 1989. The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
2. Anis NA, Berry SC, Burton NR, Lodge D. 1983. The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-D-aspartate. Br J Pharmacol 79:565-575.
3. Bristow LJ, Hutson PH, Thorn L, Tricklebank MD. 1993. The glycine/ NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic domapinergic system induced by phencyclidine and dizocilpine (MK801) in rodents. Br J Pharmacol 108:1156-1163.
4. Carlsson M, Carlsson A. 1989. The NMDA antagonist MK801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75:221-226.
5. Carlsson M, Svensson A. 1990. The non-competitive NMDA antagonists MK801 and PCP, as well as the competitive NMDAantagonists SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Life Sci 47:1729-1736.
6. Choi DW. 1987. Ionic dependence of glutamate neurotoxicity. J Neurosci 7:369-379.
7. Contreras PC. 1990. D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology 29: 291-293.
8. Contreras PC, Rice KC, Jacobson AE, O'Donohue TL. 1986. Stereo-typed behavior correlates better than ataxia with phencyclidine-receptor interactions. Eur J Pharmacol 121:9-18.
9. Di Chiara G, Morelli M, Consolo S. 1994. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17:228-233.
10. Freeman AS, Bunny BS. 1984. The effects of phencyclidine and N-allylnormatezocine on midbrain dopamine neuronal activity. Eur J Pharmacol 104:287-294.
11. French ED. 1986. Effects of phencyclidine on ventral tegmanetal A10 dopamine neurons in the rat. Neuropharmacology 25:241-248.
12. Graybiel AM. 1990. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244-254.
13. 3H]acetylcholine release from slices of rat hippocampus, striatum, and cortex. Brain Res 123:311-322.
14. Hillman GR, Kent TA, Kay A, Brunder DG, Tagare H. 1991. Measurement of brain compartment volumes in MR using voxel composition calculations. J Comput Assist Tomogr 15:640-646.
15. Jentsch JD, Anh Tran BA, Dung Le BA, Youngren KD, Phil M, Roth RH. 1997. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17: 92-99.
16. Johnson KM, Balster RL. 1981. Acute and chronic phencyclidine administration: Relationships between biodispositional factors and behavioral effects. Subst Alcohol Actions/Misuse 2:131-142.
17. Johnson KM, Phillips M, Wang C, Kevetter GA. 1998. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex. J Neurosci Res 52:709-722.
18. Kawaguchi Y. 1997. Neostriatal cell subtypes and their functional roles. Neurosci Res 27:1-8.
19. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF. 1962. Model psychosis and schizophrenia. Am J Psychiatry 119:61-96.
20. Melnick SM, Walsh JS, Clark JP, Ettenberg A. 1997. Can the behavioral sensitization to repeated phencyclidine be accounted for by tolerance to the drug's ataxic effects? Soc Neurosci Abst 23: 429.15.
21. Mori H, Mishina M. 1995. Structure and function of the NMDA receptor channel. Neuropharmacology 34:1219-1237.
22. Murray TF, Cheney DL. 1981. The effect of phencyclidine on the turnover of acetylcholine in various regions of rat brain. J Pharmacol Exp Ther 217:733-737.
23. Murray TF, Horita A. 1979. Phencyclidine-induced stereotyped behavior in rats: Dose response effects and antagonism by neuroleptics. Life Sci 24:2217-2225.
24. Nabeshima T, Yamada K, Yamaguchi K, Hiramatsu M, Furukawa H, Kameyama T. 1983. Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats. Eur J Pharmacol 91:455-463.
25. Nakanishi S. 1992. Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603.
26. Norris JC, Nabeshima T, Fontenot HJ, Wilson RD, Ho IK. 1984. Phencyclidine and GABA system. In: Narahashi T, editor. Cellular and molecular neurotoxicology. New York: Raven Press, pp 191-205.
27. Olney JW, Price MT, Samson L, Labruyere J. 1986. The role of specific ions in glutamate neurotoxicity. Neurosci Lett 65:65-71.
28. Petralia RJ, Yokotani N, Wenthold RJ. 1994. Light and electron microscope distribution of NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 14:667-696.
29. Phillips M, Wang C, Leonard G, Johnson KM. 1997. Chronic phencyclidine-induced apoptosis in rat olfactory tubercle and piriform cortex: The effects of clozapine and pentobarbital. Soc Neurosci Abstr 23:901.3.
30. Quirion R, Bayorh MA, Zerbe RL, Pert CB. 1982. Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain. Pharmacol Biochem Behav 17:699-702.
31. Richardson W, Szerb JC. 1974. The release of labelled acetylcholine and choline from cerebral cortical slices stimulated electrically. Br J Pharmacol 52:449-507.
32. Roberts AC, De Salvia MA, Wilkinson LS, Colins P, Muir JL, Everitt BJ, Robbins TW. 1994. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin card sort test: Possible interactions with subcortical dopamine. J Neurosci 14:2531-2544.
33. 3H]spiroperidol binding in rat striatum. Eur J Pharmacol 78:363-365.
34. Rothman SM. 1985. The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J Neurosci 5:1483-1489.
35. Sircar R, Follesa P, Ticku M. 1996. Postnatal phencyclidine treatment differentially regulates N-methyl-D-aspartate receptor subunit mRNA expression in developing rat cerebral cortex. Mol Brain Res 40:214-220.
36. Smith AD, Bolam JP. 1990. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci 13:259-265.
37. 3H]serotonin uptake in synaptosomal preparations from rat brain. Biochem Pharmacol 26:1435-1439.
38. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimato EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
39. Snell LD, Johnson KM. 1986. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J Pharmacol Exp Ther 238: 938-946.
40. Snell LD, Yi SJ, Johnson KM. 1988. Comparison of the effects of MK801 and phencyclidine on cetecholamine uptake and NMDA-induced norepinephrine release. Eur J Pharmacol 145:223-226.
41. Standaert DG, Testa CM, Rudolf GD, Hollingsworth ZR. 1996. Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisenseoligonucleotides reveals their role in striatal motor regulation. J Pharmacol Exp Ther 276:342-252.
42. Sturgeon RD, Fessier RG, Meltzer HY. 1979. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59:169-179.
43. Sturgeon RD, Fessier RG, London SF, Meltzer HY. 1982. Behavioral effects of chronic phencyclidine administration in rats. Psychopharmacology 76:52-56.
44. Tamminga CA, Tanimoto K, Kuo S, Chase TN, Contreras PC, Rice KC, Jackson AE, O'Donohue TL. 1987. PCP-induced alterations in cerebral glucose utilization in rat brain: Blockade by metaphit, a PCP-receptor-acylating agent. Synapse 1:497-504.
45. Tanii Y, Nishikawa T, Hashimoto A, Takahashi K. 1991. Stereoselective inhibition by D- and L-alanine of phencyclidine-induced locomotor stimulation in the rat. Brain Res 563:281-284.
46. 2 and GluR-1 glutamate receptor mRNA in the rat brain after treatment with phencyclidine. Acta Med Okayama 49:61-68.
47. Vickroy TW, Johnson KM. 1982. Similar dopamine releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices. J Pharmacol Exp Ther 223:669-674.
48. Wang C, Showalter VM, Hillman GR, Johnson KM. 1999. Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain. J Neurosci Res, in press.
49. Weissman AD, Dam M, London ED. 1987. Alterations in local cerebral glucose utilization induced by phencyclidine. Brain Res 435:29-40.
50. White IM, Flory GS, Hooper KC, Speciale J, Banks DA, Rebec GV. 1995. Phencyclidine-induced increases in striatal neurons firing in behaving rats: Reversal by haloperidol and clozapine. J Neural Transm 102:99-112.
51. Wolf ME, Khansa MR. 1991. Repeated administration of MK801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
52. Xu X, Domino EF. 1994a. Asymmetric cross-sensitization to the locomotor stimulant effects of phencyclidine and MK801. Neurochem Int 25:155-159.
53. Xu X, Domino EF. 1994b. Phencyclidine-induced behavioral sensitization. Pharmacol Biochem Behav 47:603-608.